Laboratory Test Request

Preclinical Pharmaceutical Non-GLP In-Vivo Studies

Project Description

Preclinical Pharmaceutical Contract Research Organization CRO needed for non-GLP in-vivo study of small protein analogs in 3 species for multiple therapeutic indications including a immunotherapeutic molecule for use in patients with advanced cancer as well as a potential agent for the prevention of HIV infection. We believe this compound has potential to treat SARS-CoV-2 associated acute respiratory distress syndrome (ARDS) . We would like to evaluate the compound in the Syrian hamster, hACE murine, and non-human primate models of SARS-VoV-2 ARDS. Animals would be randomized to receive OB-002 or placebo and exposed to the SARS-CoV-2 virus. Study endpoints include overall survival and the impact of treatment on histopathological changes in the lungs. We will also explore the impact of the timing of product exposure on clinical and histopathological outcomes.

Project Information

Number:20-00839

Industry:Pharmaceuticals

This request is closed and is no longer accepting quotes. Register or Log In to receive alerts when similar requests open in the future.
Biopharmaceuticals,Biosimiliars,Pharmaceutical - Small Molecules,Pharmaceuticals ,Pharmaceuticals - Large Molecules,Recombiant Proteins,

Test Request: 25-01016

MULTIPLE TESTING & SAMPLES

LONG TERM

BUDGET APPROVED ($50,000-$100,000)

We are developing a suite o... view


Test Request: 25-01012

MULTIPLE SAMPLES

BUDGET APPROVED ($1,000-$2,000)

Need laboratory testing in the USA to confirm the authen... view


Test Request: 25-01003

BUDGET APPROVED ($1,000-$2,000)

We need to test a semaglutide sample purchased from doctor's office for authent... view